LYPLA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.971800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.766000E-01
Normal-vs-Stage2
8.778600E-01
Normal-vs-Stage3
2.533000E-01
Normal-vs-Stage4
9.313400E-01
Stage1-vs-Stage2
7.220000E-01
Stage1-vs-Stage3
2.254200E-01
Stage1-vs-Stage4
7.460200E-01
Stage2-vs-Stage3
3.108400E-01
Stage2-vs-Stage4
9.330400E-01
Stage3-vs-Stage4
3.811400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.144200E-01
Normal-vs-AfricanAmerican
8.406600E-01
Normal-vs-Asian
9.265200E-01
Caucasian-vs-AfricanAmerican
9.190600E-01
Caucasian-vs-Asian
9.827000E-01
AfricanAmerican-vs-Asian
9.437600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.971000E-01
Normal-vs-Female
8.794000E-01
Male-vs-Female
9.106400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.376400E-01
Normal-vs-Age(41-60Yrs)
7.625800E-01
Normal-vs-Age(61-80Yrs)
9.366800E-01
Normal-vs-Age(81-100Yrs)
6.869200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.998380E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.231800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.201400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.553400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.055400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.458200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.285200E-01
Normal-vs-Daily Drinker
9.649200E-01
Normal-vs-Weekly Drinker
6.623000E-01
Normal-vs-Occasional Drinker
6.234800E-01
Normal-vs-Social Drinker
9.250000E-01
Non Drinker-vs-Daily Drinker
8.036400E-01
Non Drinker-vs-Weekly Drinker
4.952400E-01
Non Drinker-vs-Occasional Drinker
2.228000E-01
Non Drinker-vs-Social Drinker
7.603000E-01
Daily Drinker-vs-Weekly Drinker
4.898000E-01
Daily Drinker-vs-Occasional Drinker
4.878800E-01
Daily Drinker-vs-Social Drinker
9.076200E-01
Weekly Drinker-vs-Occasional Drinker
1.270970E-01
Weekly Drinker-vs-Social Drinker
4.959800E-01
Occasional Drinker-vs-Social Drinker
6.519600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.053600E-01
Normal-vs-Grade 2
8.284400E-02
Normal-vs-Grade 3
1.282210E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.873200E-01
Grade 1-vs-Grade 3
1.838600E-01
Grade 1-vs-Grade 4
3.053600E-01
Grade 2-vs-Grade 3
1.519790E-01
Grade 2-vs-Grade 4
8.284400E-02
Grade 3-vs-Grade 4
1.282210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.867400E-01
Normal-vs-NonDiabetic
9.453200E-01
Diabetic-vs-NonDiabetic
7.925800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.519600E-01
Normal-vs-NoPancreatitis
9.156600E-01
Pancreatitis-vs-NoPancreatitis
3.756200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.151600E-01
Normal-vs-N1
8.870800E-01
N0-vs-N1
6.800600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.094800E-01
Normal-vs-TP53-NonMutant
9.038400E-01
TP53-Mutant-vs-TP53-NonMutant
4.983500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
